House bill would push Part D price negotiations

A bipartisan bill introduced in Congress Tuesday aims to force the Trump administration's hand on Medicare Part D price negotiations, and would require HHS to bargain directly with drugmakers.

HHS Secretary Alex Azar has previously rejected the approach, which is not included in the administration’s 2018 drug pricing blueprint. The administration called for controlling Part D costs by creating a cap on Part D out-of-pocket spending (see "Trump Will Not Propose Medicare Part D Negotiation")...